Investors find safety in J&J shares, but run could stall

NEW YORK, April 14 (Reuters) - After lagging a six-year

healthcare sector run fueled by fast-growing biotech companies,

Johnson & Johnson shares have beaten the group in 2016

as investors turn to safety in rocky equity markets.

Read more